Elliot Sussman - UNIV HEALTH Independent Director
UHS Stock | EUR 154.00 3.00 1.99% |
Director
Dr. Elliot J Sussman, M.D. is Director of the Company. in March 2018. He is Chairman of The Villages Health. He previously served as President and Chief Executive Officer of Lehigh Valley Hospital and Health Network from 1993 through 2010. He was a member of the Board of Directors of iCAD, Inc. since 2002 since 2018.
Age | 67 |
Tenure | 6 years |
Similar Executives
Found 9 records | DIRECTOR Age | ||
Du Yang | Hua Hong Semiconductor | 40 | |
Long Ye | Hua Hong Semiconductor | 75 | |
Jianbo Chen | Hua Hong Semiconductor | 53 | |
Tso Chang | Hua Hong Semiconductor | 70 | |
Jing Wang | Hua Hong Semiconductor | 48 | |
Kwai Wong | Hua Hong Semiconductor | 67 | |
Yuchuan Ma | Hua Hong Semiconductor | 51 | |
Takayuki Morita | Hua Hong Semiconductor | 57 | |
Jun Ye | Hua Hong Semiconductor | 44 |
UNIV HEALTH SERV Leadership Team
Elected by the shareholders, the UNIV HEALTH's board of directors comprises two types of representatives: UNIV HEALTH inside directors who are chosen from within the company, and outside directors, selected externally and held independent of UNIV. The board's role is to monitor UNIV HEALTH's management team and ensure that shareholders' interests are well served. UNIV HEALTH's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, UNIV HEALTH's outside directors are responsible for providing unbiased perspectives on the board's policies.
Elliot Sussman, Independent Director | ||
Matthew Peterson, Executive Vice President of the company and President of Behavioral Health Division | ||
Lawrence Gibbs, Independent Director | ||
Warren Nimetz, Director | ||
Robert Hotz, Independent Director | ||
Anthony Pantaleoni, Director | ||
Steven Filton, CFO, Senior Vice President Secretary | ||
John Herrell, Independent Presiding Director | ||
Marvin Pember, Senior Vice President and Presidentident - Acute Care Division | ||
Eileen McDonnell, Lead Independent Director | ||
Alan Miller, Chairman of the Board, Chief Executive Officer | ||
Maria Singer, Independent Director | ||
Marc Miller, President Director | ||
Debra Osteen, Senior Vice President and Presidentident - Behavioral Health Care Division | ||
Steve Filton, Chief Financial Officer, Executive Vice President, Secretary | ||
Karen Sterner, IR Contact Officer |
UNIV Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is UNIV HEALTH a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Current Valuation | 13.7 B | |||
Price To Book | 1.56 X | |||
Price To Sales | 0.73 X | |||
Revenue | 13.4 B | |||
EBITDA | 1.58 B | |||
Net Income | 675.61 M | |||
Total Debt | 4.73 B | |||
Cash Flow From Operations | 996.02 M | |||
Number Of Employees | 16 | |||
Market Capitalization | 9.15 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UNIV HEALTH SERV B. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Complementary Tools for UNIV Stock analysis
When running UNIV HEALTH's price analysis, check to measure UNIV HEALTH's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UNIV HEALTH is operating at the current time. Most of UNIV HEALTH's value examination focuses on studying past and present price action to predict the probability of UNIV HEALTH's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UNIV HEALTH's price. Additionally, you may evaluate how the addition of UNIV HEALTH to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Stocks Directory Find actively traded stocks across global markets | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |